Results 81 to 90 of about 3,255,424 (314)

A New Gate Driver for IGBT Devices with Multi-protections

open access: yes机车电传动, 2015
The process of IGBT switching was analyzed, and then a new gate driver with multi-protections was designed. The contractive researches between new gate driver and common gate driver and researches on module short circuit were also done.
XIE Shunmeng   +5 more
doaj  

Determination of over current protection thresholds for class D audio amplifiers [PDF]

open access: yes2005 NORCHIP, 2005
Monolithic class-D audio amplifiers typically feature built-in over current protection circuitry that shuts down the amplifier in case of a short circuit on the output speaker terminals. To minimize cost, the threshold at which the device shuts down must be set just above the maximum current that can flow in the loudspeaker during normal operation. The
F. Nyboe, L. Risbo, P. Andreani
openaire   +1 more source

What About the Children? - FDA's Response to Pediatric Drug Testing [PDF]

open access: yes, 2012
The Federal Food and Drug Administration (FDA) has played a critical role in the protection of human subjects in research. Most recently, FDA enacted an interim final rule regarding protection of children in clinical investigations.
Doerner, Kristina M.
core  

Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson   +9 more
wiley   +1 more source

1.7 kV IGBT Driver Based on Electromagnetism Isolation

open access: yesKongzhi Yu Xinxi Jishu, 2015
The basic characteristics of IGBT driver were analyzed and an IGBT driver based on electromagnetism isolation was designed. Chopping and short-circuit test researches on the driver were executed.
XIE Shunmeng   +4 more
doaj  

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

open access: yesMolecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos   +6 more
wiley   +1 more source

MANAGING PEST RESISTANCE: THE POTENTIAL OF CROP ROTATIONS AND SHREDDING [PDF]

open access: yes
The current debate over resistance management plans mandated by the Environmental Protection Agency for transgenic crops ignores management practices that are complementary to refuge schemes.
Babcock, Bruce A., Secchi, Silvia
core   +1 more source

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen   +11 more
wiley   +1 more source

The Political Economy of Declining Industries: Senescent Industry Collapse Revisited [PDF]

open access: yes
One of the most robust empirical regularities in the political economy of trade is the persistence of protection. This paper explains persistent protection in terms of the interaction between industry adjustment, lobbying, and the political response ...
S. Lael Brainard, Thierry Verdier
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy